Patents and New Product Development in the Pharmaceutical and Biotechnology Industries (original) (raw)

The R&D-patent relationship: An industry perspective

Bruno van Pottelsberghe

2010

View PDFchevron_right

Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing

Jack Scannell

Reviews on Recent Clinical Trials, 2015

View PDFchevron_right

The More You Spend, the More You Get? The Effects of R&D and Capital Expenditures on the Patenting Activities of Biotechnology Firms

Enrico Santarelli

Working Papers, 2010

View PDFchevron_right

Changes in the field of R&D management over the past 20 years

Varghese George

R&D Management, 1989

View PDFchevron_right

Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies

Walter Moos

Drug Development Research, 1995

View PDFchevron_right

Is US Patent Policy Strong Enough to Withstand the Winds of Change: A Study of the Need to Change United States Patent Policy

Stephanie Alexis

Is US Patent Policy Strong Enough to Withstand the Winds of Change: A Study of the Need to Change United States Patent Policy, 2015

View PDFchevron_right

The search for new drugs: a theory of R&D in the pharmaceutical industry

Nguyen Quyen

Journal of Economic Studies, 2017

View PDFchevron_right

Patents and R&D Incentives: Comments on the Hubbard and Love Trade Framework for Financing Pharmaceutical R&D

Joseph DiMasi

Submission to the Commission on Intellectual …, 2004

View PDFchevron_right

Research and Development (R&D) in the Pharmaceutical Sector: advances, limitations, selectivity, and neglect

João Stacciarini

Revista Terceiro Incluído, 2024

View PDFchevron_right

Are we running out of new ideas? A look at patents and R&D

Daniel Wilson

2003

View PDFchevron_right

A Policy Insight into the R&D-Patent Relationship

Bruno van Pottelsberghe

Social Science Research Network, 2009

View PDFchevron_right

Ownership of knowledge--the role of patents in pharmaceutical R&D

carlos correa

Bulletin of The World Health Organization, 2004

View PDFchevron_right

Patents and Other Incentives for Pharmaceutical Innovation

Paul Grootendorst

Encyclopedia of Health Economics, 2014

View PDFchevron_right

Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D

Fabio Pammolli

European Management Review, 2012

View PDFchevron_right

Cost of innovation in the pharmaceutical industry

Joseph DiMasi

Journal of Health Economics, 1991

View PDFchevron_right

Pharmaceutical research and development: what do we get for all that money

Donald Light

View PDFchevron_right

How do the Social Benefits and Costs of the Patent System Stack Up in Pharmaceuticals?

Daniel Gifford

Bepress Legal Series, 2004

View PDFchevron_right

Patents and R and D at the Firm Level: A First Look

Ariel Pakes

1980

View PDFchevron_right

Patents and Medical Biotechnology: An Empirical Analysis of Issues Facing the Australian Industry

Dianne Nicol

SSRN Electronic Journal, 2000

View PDFchevron_right

Analysis of the evolution of the costs of research–trends, drivers and impacts

Jeff Butler

2011

View PDFchevron_right

Commentary: Do Patent Terms Impact Domestic R&D Spending in the Pharmaceutical Industry?

Harold Schroeder

Healthcare Policy | Politiques de Santé, 2007

View PDFchevron_right

Policymakers and the R&D-patent relationship

Bruno van Pottelsberghe

Intereconomics, 2008

View PDFchevron_right

Challenges to the Patent System

Giuseppina D'Agostino

SSRN Electronic Journal, 2011

View PDFchevron_right

The Relationship Between Publications and Patents by Researchers at Five Companies

Kwanghui Lim

2000

View PDFchevron_right

Technological paradigms and trajectories as determinants of the R&D corporate change in drug discovery industry

Mario Coccia

View PDFchevron_right

Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery

Iain Cockburn

The RAND Journal of Economics, 1996

View PDFchevron_right

Evaluating Innovation in the Pharmaceutical Industry 1

Paris Cleanthous

2000

View PDFchevron_right

Big Pharma, little science? A bibliometric perspective on big pharma's R&D decline

Antonio Perianes-Rodriguez

2013

View PDFchevron_right

Innovation in the pharmaceutical industry: New estimates of R&D costs

Joseph DiMasi

Journal of Health Economics, 2016

View PDFchevron_right

Returns on Research and Development for 1990s New Drug Introductions

Joseph DiMasi

PharmacoEconomics, 2002

View PDFchevron_right

President Information Technology and Innovation Foundation The Globalization of R&D and Innovation: How Do Companies Choose Where to Build R&D Facilities? before the Committee on Science and Technology Subcommittee on Technology and Innovation U.S. House of Representatives

Robert D Atkinson

View PDFchevron_right

Management control of biomedical research and pharmaceutical innovation

Jo Van Engelen

Technovation, 1997

View PDFchevron_right

Changing patterns in industrial R&D management

David Wilemon

Journal of Product Innovation Management, 1996

View PDFchevron_right

THE IMPACT OF ACADEMIC PATENTING ON THE RATE, QUALITY AND DIRECTION OF (PUBLIC) RESEARCH OUTPUT

Pierre Azoulay

The Journal of Industrial Economics, 2009

View PDFchevron_right

The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: policy issues

Giovanni Dosi

The Case of Pharma-Biotech, 2006

View PDFchevron_right